Clinical and genotypic characteristics of infantile inflammatory bowel disease
10.3760/cma.j.issn.0578-1310.2019.07.005
- VernacularTitle: 婴幼儿炎症性肠病的临床及基因型分析
- Author:
Youzhe GONG
1
;
Huijuan NING
;
Xin MA
;
Dan ZHU
;
Fuping WANG
;
Ran ZHANG
;
Yanling ZHANG
;
Xuemei ZHONG
Author Information
1. Department of Gastroenterology, Children′s Hospital, Capital Institute of Pediatrics, Beijing 100020, China
- Publication Type:Journal Article
- Keywords:
Retrospective studies;
Infant;
Genes
- From:
Chinese Journal of Pediatrics
2019;57(7):520-525
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical and genotypic characteristics of infantile inflammatory bowel disease (IBD).
Methods:The age of onset, family history, clinical manifestations, and treatment effect were retrospectively analyzed in 39 infants (male 23 cases, female 16 cases) with IBD who were admitted to the Department of Gastroenterology in Children′s Hospital, Capital Institute of Pediatrics from January 2007 to December 2017. Next generation sequencing (NGS) based on target gene panel was used for gene analysis in 17 patients.
Results:The median age of onset was 0.5 (0.5, 1.0) month. The most common clinical symptoms included diarrhea (39, 100%), malnutrition (38, 97%), hematochezia (34, 87%), fever (25, 64%), and perianal diseases (24, 61%). Four children had associated family history. Among the 17 patients whose gene was analyzed, 10 were found to have the pathogenic gene variation, within whom 7 had interleukin-10 receptor α subunit (IL-10RA) mutation, 2 had CYBB heterozygous mutation, 1 had interleukin-10 receptor β subunit (IL-10RB) mutation. The therapeutic medicine included mesalazine, steroids, and thalidomide. Eighteen children (46%) reached clinical remission (10 cases) or partial remission (8 cases).
Conclusions:The incidence of single gene mutation in infants with IBD is high, with IL-10RA mutation as the most common. Refractory diarrhea and malnutrition may indicate infantile IBD.
